about
MAP kinase phosphatase-2 plays a key role in the control of infection with Toxoplasma gondii by modulating iNOS and arginase-1 activities in miceThe benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme targetParasites lacking the micronemal protein MIC2 are deficient in surface attachment and host cell egress, but remain virulent in vivoT cell hypo-responsiveness against Leishmania major in MAP kinase phosphatase (MKP) 2 deficient C57BL/6 mice does not alter the healer disease phenotype.Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 miceNew paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections.Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondiiDesign, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.Acanthamoeba Activates Macrophages Predominantly through Toll-Like Receptor 4- and MyD88-Dependent Mechanisms To Induce Interleukin-12 (IL-12) and IL-6.CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondiiNovel protective role for MAP kinase phosphatase 2 in inflammatory arthritisMulti-Omics Studies Demonstrate Toxoplasma gondii-Induced Metabolic Reprogramming of Murine Dendritic CellsExploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatmentsA novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations
P50
Q27334138-8F8D2EF8-1BBC-410F-86A1-7E73FFCEFA24Q27681222-53ADD080-F6AE-495F-9880-F51E66C3535BQ30855883-F109FAC8-FCCA-43C4-B2DE-6D4E5321BA49Q34600685-98AAB9FD-D080-4F89-8D3E-24CB3C086832Q35634197-CCA5B2F7-C976-44C9-B1A3-8D787A848EC5Q37093155-A7F54405-8DF3-4339-9F34-F910ED3181F0Q37128281-D81E4A3A-44C7-4347-AFE8-103447063B3AQ37277042-C125B15A-563E-4C15-8609-70B3F3DB5BA9Q39812716-EA203B15-1B93-44C0-A173-BEB83E154E22Q40276593-CBFDCAC1-6DDA-445A-A41D-11AED5650804Q57817903-7F86FD29-87A8-4B72-9ADF-9E98A280DE88Q61797055-E9F21EEB-DB30-4283-8CF9-23BD7B3151DBQ90403289-511D8CEC-4C5C-4AC1-B2DD-2449F775D73FQ91399697-8A2C91E5-70ED-496F-8951-A817B8E04789Q92839506-EAF4C35B-856E-4E85-BC8C-F513A1AC6127
P50
description
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Stuart Woods
@ast
Stuart Woods
@en
Stuart Woods
@en-gb
Stuart Woods
@es
Stuart Woods
@nl
Stuart Woods
@sl
type
label
Stuart Woods
@ast
Stuart Woods
@en
Stuart Woods
@en-gb
Stuart Woods
@es
Stuart Woods
@nl
Stuart Woods
@sl
prefLabel
Stuart Woods
@ast
Stuart Woods
@en
Stuart Woods
@en-gb
Stuart Woods
@es
Stuart Woods
@nl
Stuart Woods
@sl
P106
P1153
37027541700
P31
P496
0000-0002-3798-2074